Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul M Tulkens

Showing results (1-10 of 169) with videos related to

Pageof 17
Sort By:
The Journal of Infectious Diseases|January 23, 2020
Phosphocholine May Allow for Listeriolysin-Mediated Escape of Phagocytized Listeria From Vacuolar Compartments Into the Host Cytosol While Protecting Against Overt Destruction of the Infected CellPaul M Tulkens
The Journal of Antimicrobial Chemotherapy|December 1, 2021
Current and future options for treating complicated skin and soft tissue infections: focus on fluoroquinolones and long-acting lipoglycopeptide antibioticsChristian Eckmann, Paul M Tulkens
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 27, 2015
Editorial Commentary: Colistin and a New Paradigm in Drug DevelopmentFrançoise Van Bambeke, Paul M Tulkens
The Journal of Antimicrobial Chemotherapy|May 19, 2011
Hepatic safety of antibiotics used in primary careRaúl J Andrade, Paul M Tulkens
Drug Safety|May 8, 2009
Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classesFrançoise Van Bambeke, Paul M Tulkens
The Journal of Antimicrobial Chemotherapy|December 20, 2008
Temocillin revivedDavid M Livermore, Paul M Tulkens
Expert Review of Anti-Infective Therapy|February 6, 2016
The role of solithromycin in the management of bacterial community-acquired pneumoniaFrançoise Van Bambeke, Paul M Tulkens
Drugs in R&D|June 22, 2012
Moxifloxacin safety: an analysis of 14 years of clinical dataPaul M Tulkens, Pierre Arvis, Frank Kruesmann
The Journal of Antimicrobial Chemotherapy|June 26, 2010
Long-term stability of temocillin in elastomeric pumps for outpatient antibiotic therapy in cystic fibrosis patientsStéphane Carryn, Nathalie Couwenbergh, Paul M Tulkens
Antimicrobial Agents and Chemotherapy|January 24, 2018
Cellular Pharmacokinetics and Intracellular Activity of Gepotidacin against Staphylococcus aureus Isolates with Different Resistance Phenotypes in Models of Cultured Phagocytic CellsFrédéric Peyrusson, Paul M Tulkens, Françoise Van Bambeke
Pageof 17

Showing results (1-10 of 169) with videos related to

Sort By:
Pageof 17
The Journal of Infectious Diseases|January 23, 2020
Phosphocholine May Allow for Listeriolysin-Mediated Escape of Phagocytized Listeria From Vacuolar Compartments Into the Host Cytosol While Protecting Against Overt Destruction of the Infected CellPaul M Tulkens
The Journal of Antimicrobial Chemotherapy|December 1, 2021
Current and future options for treating complicated skin and soft tissue infections: focus on fluoroquinolones and long-acting lipoglycopeptide antibioticsChristian Eckmann, Paul M Tulkens
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 27, 2015
Editorial Commentary: Colistin and a New Paradigm in Drug DevelopmentFrançoise Van Bambeke, Paul M Tulkens
The Journal of Antimicrobial Chemotherapy|May 19, 2011
Hepatic safety of antibiotics used in primary careRaúl J Andrade, Paul M Tulkens
Drug Safety|May 8, 2009
Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classesFrançoise Van Bambeke, Paul M Tulkens
The Journal of Antimicrobial Chemotherapy|December 20, 2008
Temocillin revivedDavid M Livermore, Paul M Tulkens
Expert Review of Anti-Infective Therapy|February 6, 2016
The role of solithromycin in the management of bacterial community-acquired pneumoniaFrançoise Van Bambeke, Paul M Tulkens
Drugs in R&D|June 22, 2012
Moxifloxacin safety: an analysis of 14 years of clinical dataPaul M Tulkens, Pierre Arvis, Frank Kruesmann
The Journal of Antimicrobial Chemotherapy|June 26, 2010
Long-term stability of temocillin in elastomeric pumps for outpatient antibiotic therapy in cystic fibrosis patientsStéphane Carryn, Nathalie Couwenbergh, Paul M Tulkens
Antimicrobial Agents and Chemotherapy|January 24, 2018
Cellular Pharmacokinetics and Intracellular Activity of Gepotidacin against Staphylococcus aureus Isolates with Different Resistance Phenotypes in Models of Cultured Phagocytic CellsFrédéric Peyrusson, Paul M Tulkens, Françoise Van Bambeke
Pageof 17